ArticleInternational journal of molecular sciences2022

The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications.

Arnold Péter Ráduly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.